3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
15
Ovarian Neoplasms
3
Colorectal Neoplasms
3
Neoplasms, Unknown Primary
2
Hereditary Breast and Ovarian Cancer Syndrome
2
Carcinoma, Intraductal, Noninfiltrating
2
Brain Neoplasms
2
Women Age 35+ Qualifies if >15% Lifetime Risk of Breast Cancer as Defined by IBIS Version 8
1
Urogenital Neoplasms
1
Primary Ovarian Insufficiency
1
Neoplastic Syndromes, Hereditary
1
Neoplasm Metastasis
1
Hot Flashes
1
Head and Neck Neoplasms
1
HER2-positive Breast Cancer
1
Digestive System Neoplasms
1
Depression
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Central Nervous System Neoplasms
1
Cardiovascular Diseases
1
Breast Screening
1
Breast Neoplasms, Male
1
Breast Carcinoma In Situ
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Paclitaxel
50
Capecitabine
50
Trastuzumab
38
Fulvestrant
31
pembrolizumab
27
Cyclophosphamide
27
Carboplatin
27
Gemcitabine
23
Letrozole
21
palbociclib
19
Docetaxel
19
Lapatinib
18
Bevacizumab
18
exemestane
17
eribulin
15
Everolimus
14
abemaciclib
13
Vinorelbine
13
Nivolumab
13
Magnetic Resonance Spectroscopy
12
Cisplatin
12
Anastrozole
12
trastuzumab deruxtecan
11
Zoledronic Acid
11
Doxorubicin
11
Albumin-Bound Paclitaxel
11
olaparib
10
Tamoxifen
10
Specimen Handling
10
Radiotherapy
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Genetic Testing
×
Breast
×
Clear all
NCT01460186
2019-01-15
StoRM
Centre Leon Berard
Phase NA
Completed
1,000 enrolled